Theriva Biologics Inc (TOVX)
1.68
-0.11
(-6.15%)
USD |
NYAM |
Oct 04, 16:00
1.60
-0.08
(-4.76%)
After-Hours: 20:00
Theriva Biologics Shareholders Equity (Annual): 39.70M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 39.70M |
December 31, 2022 | 54.56M |
December 31, 2021 | 65.41M |
December 31, 2020 | 8.031M |
December 31, 2019 | 14.36M |
December 31, 2018 | 29.36M |
December 31, 2017 | 10.56M |
December 31, 2016 | 3.845M |
December 31, 2015 | 16.05M |
December 31, 2014 | 9.556M |
December 31, 2013 | 15.23M |
December 31, 2012 | 13.03M |
December 31, 2011 | 7.059M |
December 31, 2010 | 3.579M |
December 31, 2009 | 3.544M |
Date | Value |
---|---|
December 31, 2008 | 6.765M |
December 31, 2007 | 11.95M |
December 31, 2006 | 11.79M |
December 31, 2005 | -0.7038M |
December 31, 2002 | -15.39M |
December 31, 2001 | -9.086M |
December 31, 2000 | -0.4137M |
December 31, 1999 | 0.6711M |
December 31, 1998 | 0.70M |
December 31, 1997 | -2.20M |
December 31, 1996 | 1.70M |
December 31, 1995 | 1.80M |
December 31, 1994 | -0.60M |
December 31, 1993 | 1.70M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
8.031M
Minimum
2020
65.41M
Maximum
2021
36.41M
Average
39.70M
Median
2023
Shareholders Equity (Annual) Benchmarks
BioCardia Inc | -1.603M |
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -0.1115M |
iBio Inc | 21.32M |
Oragenics Inc | 3.168M |